The urgent need for improved support for SEND pupils

Pupils with special educational needs and disabilities (SEND) are continuing to fall behind their peers with the gap widening despite the introduction of SEND legislation.

$4.1 million funding supports epilepsy treatment research using spider venom proteins

UQ researchers have received $4.1 million from the Medical Research Future Fund to advance their research into epilepsy treatments made from spider venom proteins.

September 17, 2024

OTC naloxone nasal spray to cost about as much as the brand-name, prescription version

The FDA recently approved multiple over-the-counter (OTC) versions of the nasal spray that can reverse opioid overdoses, promising new low-cost competitors. But now a nonprofit

August 10, 2023

Vitestro Secures $22M for Autonomous Blood Draw Device

What You Should Know: – Vitestro, the pioneering autonomous blood drawing company, today announced that it has raised $22 million (€20 million) funding to accelerate

April 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.